AKT1 and neoplasm: PTEN-lipid-phosphatase activity is critical for its tumor-suppressor function, which antagonizes the PI3K–AKT/PKB signaling pathway by dephosphorylating phosphoinositides, thereby modulating the cell-cycle progression and cell survival [7].